Class Action

E25Bio COVID-19 Direct Antigen Rapid Tests

Class Action

E25Bio COVID-19 Direct Antigen Rapid Tests


Case Name (Date)

Urena et al. v. E25Bio Inc.
22-cv-1379, S.D.N.Y.
(Feb. 2022)


Product/Service

E25Bio COVID-19 Direct Antigen Rapid Tests


Allegations

Falsely marketing tests as accurate when they are significantly less accurate than other at-home tests

Falsely representing that tests are authorized by the FDA


Status

Voluntarily dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.



The Latest

Filters

72SOLD

Ad Alert

72SOLD

What to know about this real estate company’s advertising.


Show More